Skip to content
Ejaculation.org

Randomised controlled trial · 2010

Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase III, double-blind, placebo-controlled study

Carson C, Wyllie M (2010). Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase III, double-blind, placebo-controlled study. The Journal of Sexual Medicine. doi:10.1111/j.1743-6109.2010.01913.x

Key finding
In 256 men with lifelong PE, a metered lidocaine–prilocaine spray applied 5 minutes before sex raised average latency from 0.56 to 2.60 minutes over 3 months, versus 0.53 to 0.80 minutes on placebo.

Summary

PSD502 is a metered-dose aerosol spray containing two local anaesthetics, lidocaine and prilocaine, developed for lifelong premature ejaculation (PE). It was later approved in the European Union and is sold there under the name Fortacin. This was one of two double-blind, placebo-controlled phase III trials.

Men with lifelong PE who recorded an intravaginal ejaculatory latency time (IELT: the time from penetration to ejaculation) of 1 minute or less in at least two of their first three encounters during a four-week baseline were randomised to the spray or a placebo spray for three months. In total, 256 men from 38 centres in the United States, Canada and Poland took part. The spray was applied to the glans (head) of the penis 5 minutes before intercourse, and IELT was timed with a stopwatch at each encounter.

Geometric mean IELT rose from 0.56 to 2.60 minutes with the active spray and from 0.53 to 0.80 minutes with placebo. Scores for ejaculatory control, sexual satisfaction and distress on the Index of Premature Ejaculation improved significantly more with the active spray. The authors describe the spray as well tolerated by patients and partners.

Limitations

This was a trial from the product's own development programme (check the full paper for funding and author disclosures). It lasted three months and included only men with lifelong PE and a very short baseline latency. It says nothing about how the benefit holds up after stopping. Because an active anaesthetic can sometimes be felt, blinding may not have been perfect.

What it means for you

A properly formulated anaesthetic spray can produce a real, measurable gain in time and in the feeling of control for men with lifelong PE, on average from about half a minute to about two and a half minutes in this trial. It works only on the occasions you use it, and it reduces sensation rather than training control, so it fits best as a short-term aid or alongside training.